These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8944665)

  • 41. Somatostatin-sensitive neural system in the liver.
    Nakabayashi H; Niijima A; Kurata Y; Usukura N; Takeda R
    Neurosci Lett; 1986 Jun; 67(1):78-81. PubMed ID: 2873532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reflex control of the autonomic nervous system activity from the glucose sensors in the liver in normal and midpontine-transected animals.
    Niijima A
    J Auton Nerv Syst; 1984; 10(3-4):279-85. PubMed ID: 6090524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. tGLP-1 and release of vasopressin and oxytocin from the isolated rat hypothalamo-neurohypophysial system: effects of a tGLP-1 receptor agonist and antagonist.
    Bojanowska E; Stempniak B
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 2):781-93. PubMed ID: 11785773
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepato-vagal pathway associated with nicotine's anorectic effect in the rat.
    Niijima A; Miyata G; Sato T; Meguid MM
    Auton Neurosci; 2001 Oct; 93(1-2):48-55. PubMed ID: 11695706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucagon satiety: diurnal variation after hepatic branch vagotomy or intraportal alloxan.
    Weatherford SC; Ritter S
    Brain Res Bull; 1986 Oct; 17(4):545-9. PubMed ID: 3779455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion.
    Rocca AS; Brubaker PL
    Endocrinology; 1999 Apr; 140(4):1687-94. PubMed ID: 10098504
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.
    Kieffer TJ; McIntosh CH; Pederson RA
    Endocrinology; 1995 Aug; 136(8):3585-96. PubMed ID: 7628397
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways.
    Sabbatini ME; Rodríguez MR; Dabas P; Vatta MS; Bianciotti LG
    Eur J Pharmacol; 2007 Dec; 577(1-3):192-202. PubMed ID: 17900562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Visceral afferents and metabolic function.
    Niijima A
    Diabetologia; 1981 Mar; 20 Suppl():325-30. PubMed ID: 7014328
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake.
    Weatherford SC; Ritter S
    Physiol Behav; 1988; 43(5):645-50. PubMed ID: 3200921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of glycated glucagon-like peptide-1(7-36)amide in intestinal tissue of normal and diabetic animal models.
    Mooney MH; Abdel-Wahab YH; McKillop AM; O'Harte FP; Flatt PR
    Biochim Biophys Acta; 2002 Jan; 1569(1-3):75-80. PubMed ID: 11853960
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop.
    Roberge JN; Brubaker PL
    Endocrinology; 1993 Jul; 133(1):233-40. PubMed ID: 8319572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reflex effects from leptin sensors in the white adipose tissue of the epididymis to the efferent activity of the sympathetic and vagus nerve in the rat.
    Niijima A
    Neurosci Lett; 1999 Mar; 262(2):125-8. PubMed ID: 10203247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.
    Nelson DW; Sharp JW; Brownfield MS; Raybould HE; Ney DM
    Endocrinology; 2007 May; 148(5):1954-62. PubMed ID: 17234710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
    Rüttimann EB; Arnold M; Hillebrand JJ; Geary N; Langhans W
    Endocrinology; 2009 Mar; 150(3):1174-81. PubMed ID: 18948395
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central glucagon like peptide-1 inhibits reflex swallowing elicited by the superior laryngeal nerve via caudal brainstem in the rat.
    Kobashi M; Mizutani S; Fujita M; Mitoh Y; Shimatani Y; Matsuo R
    Brain Res; 2017 Sep; 1671():26-32. PubMed ID: 28693820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of umami taste stimulations on vagal efferent activity in the rat.
    Niijima A
    Brain Res Bull; 1991; 27(3-4):393-6. PubMed ID: 1959036
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of DQ-2511 on neutral activity in afferent and efferent loops of gastric vago-vagal reflex pathways in the rat.
    Niijima A; Hatanaka S; Furuhama K
    J Auton Pharmacol; 1996 Feb; 16(1):49-53. PubMed ID: 8736431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans.
    Schirra J; Sturm K; Leicht P; Arnold R; Göke B; Katschinski M
    J Clin Invest; 1998 Apr; 101(7):1421-30. PubMed ID: 9525985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T; Krarup T; Madsbad S; Holst JJ
    Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.